India Active Pharmaceutical Ingredients Market to Grow at a Formidable Rate During the Forecast Period
Increasing incidence of
chronic diseases is expected to drive the growth of India Active Pharmaceutical
Ingredients market during the forecast period.
According to
TechSci Research report, “India Active Pharmaceutical
Ingredients Market By Drug Type (Acyclovir, Amoxicillin, Artesunate,
Aspirin, Atorvastatin, Azithromycin, Betamethasone, Carbamazepine, Carbidopa,
Cefixime, Cefoperazone, Others), By Source (In-house v/s Contract Manufacturing
Organizations), By Distribution Channel (Online v/s Offline), By Therapeutic
Application (Cardiovascular Diseases, Skin Infections, Neurological Disorders,
Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Bacterial
Infections, Others), By Form (Tablet, Capsule, Injection, Others), By Route of Administration
(Oral v/s Intravenous), By End User (Adult v/s Pediatric), By Company, By
Region, Forecast & Opportunities, FY2026”, the India Active Pharmaceutical Ingredients market is
expected to grow at a formidable rate during the forecast period on account of surging
drug research and development. Rising prevalence of chronic ailments such as
CVDs, arthritis, and diabetes, coupled with increasing count of infectious
diseases like influenza, hepatitis, and coronavirus in the country are
bolstering the demand for drugs and medications. In addition to this, growing
importance of generics is further expected to fuel the market growth through
FY2026. Also, mounting incidence of obesity in India is estimated to drive the
demand for APIs. However, unfavorable drug price control policies across
various countries can restrict the market growth over the next few years.
Moreover, high manufacturing costs of APIs can further hinder the market growth
during the forecast period.
Browse
XX market data Tables and XX Figures spread through XX Pages and an
in-depth TOC on " India Active Pharmaceutical
Ingredients Market"
https://www.techsciresearch.com/report/india-active-pharmaceutical-ingredients-market/7277.html
The India
Active Pharmaceutical Ingredients market is segmented based on drug type,
source, distribution channel, therapeutic application, form, route of
administration, end user, company, and region. Based on route of administration,
the market can be fragmented into oral v/s intravenous. The oral route of
administration segment is expected to dominate the market in the forthcoming
years on account of its versatility to accommodate various types of drugs.
Moreover, the oral route is the most convenient and usually the safest, thereby
positively influencing the segmental growth in the upcoming years. Based on source,
the market can be categorized into in-house v/s contract manufacturing
organizations. The in-house segment dominated the market until FY2020 as most
of the leading companies focus on in house production. Contract manufacturing
organizations segment is expected to witness significant growth in the market
as it saves cost and maximizes profit. Besides, high growth in number of
contract manufacturers is further contributing to its fast growing CAGR.
Cipla Ltd., Dr.
Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Cadila Pharmaceuticals
Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceuticals Industries
Ltd., Taj Pharmaceuticals Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Torrent
Pharmaceuticals Ltd., Fresenius Kabi India Pvt. Ltd. and others are
some of the leading players operating in India Active Pharmaceutical
Ingredients market. Companies operating in the market are using organic
strategies such as product launches, mergers and acquisitions and research
collaborations to boost their share and increase their geographic reach.
Download
Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7277
Customers can also request
for 10% free customization on this report.
“India Active Pharmaceutical
Ingredients market is expected to witness high growth during the forecast
period which is attributable to increasing uptake of biopharmaceuticals.
Additionally, major market players are focusing on strategic collaborations to
commercialize their newly developed drugs. This is further expected to create
lucrative opportunities for the market growth of India Active Pharmaceutical
Ingredients market over the next five years.” said Mr. Karan Chechi, Research
Director with TechSci Research, a
research based global management consulting firm.
“India Active Pharmaceutical Ingredients Market
By Drug Type (Acyclovir, Amoxicillin, Artesunate, Aspirin, Atorvastatin,
Azithromycin, Betamethasone, Carbamazepine, Carbidopa, Cefixime, Cefoperazone,
Others), By Source (In-house v/s Contract Manufacturing Organizations), By
Distribution Channel (Online v/s Offline), By Therapeutic Application
(Cardiovascular Diseases, Skin Infections, Neurological Disorders, Orthopedic
Disorders, Respiratory, Gastrointestinal Disorders, Bacterial Infections,
Others), By Form (Tablet, Capsule, Injection, Others), By Route of
administration (Oral v/s Intravenous), By End User (Adult v/s Pediatric), By
Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India Active
Pharmaceutical Ingredients market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges and opportunities in India Active
Pharmaceutical Ingredients market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel:
+1-646-360-1656
Email: [email protected]